Hospital Overview
Institutional Profile and Positioning
Fudan University Shanghai Cancer Center (FUSCC) is a National Health Commission-affiliated, Grade-A tertiary academic cancer hospital and one of China's longest-established dedicated oncology institutions, founded in 1931. The center integrates clinical care, medical education, translational research, and cancer prevention within a comprehensive academic medical system comparable to leading international cancer centers.
Campus Integration and System Development
Operating across two highly integrated campuses, the main Xuhui site and the Shanghai Proton and Heavy Ion Hospital in Pudong, FUSCC functions as a national referral hub for complex oncology care. The institution is currently advancing toward designation as a National Cancer Medical Center and serves as a pilot site for high-quality governance and performance improvement among public hospitals in Shanghai.
Scale, Capacity, and Clinical Outcomes
As of 2023, FUSCC operates 2,149 inpatient beds across 43 clinical and technical departments, supported by nearly 3,000 healthcare professionals. Its care delivery model emphasizes multidisciplinary treatment planning, precision oncology, minimally invasive surgery, and full-cycle patient management supported by digital health and intelligent hospital initiatives.
Clinical outcomes demonstrate strong international comparability: the reported five-year overall survival rate of 71.6% ranks among the highest nationally and aligns with outcomes reported in developed healthcare systems. FUSCC maintains a robust quality infrastructure, including pathology and radiotherapy quality control centers, national drug clinical trial accreditation, and multiple state and municipal key specialty programs.
Research and Global Collaboration
The institution combines high clinical volume with research productivity and global collaboration, supporting large-scale clinical trials, translational innovation, and participation in international oncology guideline development. Strategic partnerships with leading global institutions, including MD Anderson Cancer Center, further reinforce its commitment to international standards, clinical governance maturity, and cross-border scientific exchange.
Key Highlights
National-Level Academic Cancer Center
- Established in 1931 as China's earliest specialized cancer institution.
- National Health Commission-affiliated Grade-A tertiary hospital.
- Candidate institution for National Cancer Medical Center designation.
Scale and Clinical Capacity
- 2,149 beds and 43 clinical and technical departments.
- Approximately 2,979 staff members including nationally recognized oncology experts.
- 2023 volumes: 2.02 million outpatient visits, 163,800 inpatient admissions, and 71,000 surgeries.
Advanced Oncology Infrastructure
- Integrated proton and heavy ion therapy facility.
- Precision Oncology Center and Cell & Gene Therapy Center.
- Multidisciplinary disease-specific treatment programs and intelligent hospital systems.
Quality and Outcomes
- Five-year survival rate: 71.6%, comparable to developed-country benchmarks.
- Accredited national drug clinical trial institution.
- Regional pathology and radiotherapy quality control leadership.
Research and Innovation
- 89 newly funded National Natural Science Foundation projects in 2023.
- High-impact publications (IF > 10) and award-winning research achievements.
- 424 newly approved clinical studies, including international multicenter trials.
- Contributions to more than 80 updates in international oncology guidelines.
Talent and Education Leadership
- National and municipal oncology training bases for residents and specialists.
- Extensive leadership roles held by faculty in national and international oncology societies.
Networked Care and Public Health Impact
- Oncology consortium spanning approximately 100 affiliated institutions.
- Regional and international medical outreach programs.
- Active global collaborations, including partnership with MD Anderson Cancer Center.
International Alignment
- Emphasis on evidence-based medicine, translational research, and standardized care pathways.
- Expanding global clinical collaboration and academic exchange to enhance comparability with Western oncology systems.
Key Specialized Departments Overview
Breast Surgery Department
A leading research and clinical program focused on comprehensive breast cancer care, with particular strength in Triple-Negative Breast Cancer (TNBC). The department manages one of the world's largest single-center multi-omics breast cancer cohorts and has established a large-scale genomic mutation landscape supporting precision oncology. Research outputs contribute to biomarker-driven therapy development and immunotherapy strategies aligned with international precision medicine standards.
Thoracic Surgery Department
A designated top-tier clinical specialty specializing in lung and esophageal cancers. The team has advanced next-generation minimally invasive thoracic surgical approaches and early-stage lung adenocarcinoma treatment strategies that have informed international clinical practice and guideline development.
Pancreatic Surgery Department
A national key clinical specialty dedicated to pancreatic cancer and neuroendocrine tumors. The department has developed validated staging methodologies and serum biomarker systems that support earlier diagnosis, risk stratification, and measurable improvements in clinical outcomes.
Urology Department
A high-volume prostate cancer center delivering evidence-based, personalized treatment strategies, including neoadjuvant and advanced-stage therapeutic protocols. The program actively participates in multicenter clinical research and translational drug development, maintaining strong surgical volume and standardized quality outcomes.
Head and Neck Surgery Department
Provides multidisciplinary management of thyroid, laryngeal, and related malignancies, integrating advanced surgical techniques with modern oncologic treatment planning.
Gastric Surgery Department
Focused on standardized, guideline-aligned surgical care and multimodal treatment pathways for gastric cancer, emphasizing consistency, safety, and outcome optimization.
Liver Surgery Department
Recognized for integrated surgical, interventional, and systemic treatment approaches for liver cancer, supported by multidisciplinary decision-making and comprehensive perioperative management.
Colorectal Surgery Department
Delivers coordinated colorectal cancer care combining surgery, systemic therapy, and targeted treatments within structured multidisciplinary treatment (MDT) frameworks.
Gynecologic Oncology Department
Provides comprehensive management of cervical, ovarian, and endometrial cancers through evidence-based treatment pathways integrating surgery, chemotherapy, and precision oncology approaches.
Radiation Oncology Center
A major institutional strength equipped with advanced radiotherapy platforms enabling highly precise treatment delivery, including proton and heavy-ion therapy through an affiliated proton and heavy-ion facility. The center operates under standardized treatment protocols and rigorous quality assurance systems comparable to leading international radiation oncology programs.
Integrative Oncology Program
Combines evidence-informed traditional and conventional medical approaches to support symptom management, treatment tolerance, and patient quality of life within a supervised clinical framework.
Pathology Department
A nationally recognized academic pathology program providing high-level tumor diagnostics and molecular pathology services. The department supports precision treatment decisions through standardized testing workflows, quality-controlled laboratories, and advanced genomic analysis.
Precision Oncology Center & Cell and Gene Therapy Center
Dedicated platforms supporting translational research, biomarker-guided therapy, and emerging cell and gene therapy applications, reflecting institutional capabilities in advanced oncology innovation and clinical implementation.
International Patient Services
1. Key Features of International Medical Services:
FUSCC welcomes international patients and is one of Shanghai's designated public hospitals participating in the International Medical Tourism Pilot Program. The institution maintains structured support systems for overseas visitors, including English-speaking clinical staff and professional medical interpretation services available for complex consultations upon request.
The hospital operates a comprehensive range of clinical and medical technology departments with strong capabilities in cancer diagnosis and treatment. Core areas of expertise include breast cancer, lung cancer, gastric cancer, and liver cancer, supported by multidisciplinary care models aligned with modern oncology standards.
Specialized Clinical Programs
Key specialty services frequently accessed by international patients include:
- Breast Cancer Center: Comprehensive diagnosis, surgery, and precision oncology care.
- Pathology Services: Advanced tumor pathology and molecular diagnostic capabilities supporting evidence-based treatment planning.
- Proton and Heavy Ion Therapy: Access to advanced particle therapy through an affiliated proton and heavy-ion treatment facility, enabling highly precise radiotherapy for selected cancer indications.
2. Fees & Payment
- Consultation: RMB 300-500 (general or specialist consultations)
- VIP Clinic Hospitalization: between RMB 800 and RMB 3,500.
- Insurance: Direct billing for approved plans
3. Service Info
Multilingual Support
English-speaking physicians and nursing staff are available to assist international patients. Professional interpreter services can be arranged to ensure accurate clinical communication and informed decision-making.
While there is no separate 24-hour emergency unit exclusively for international patients, all patients have full access to the hospital's general Emergency Department, which operates under standardized triage and care protocols.
4. Contact Info
General, Specialist, and Premium Outpatient Appointments
Phone: +86 21 95169 (English support may be limited).
Hours: Monday-Friday, 07:30-17:00
Fee: Free hotline service
Services: General outpatient, specialist consultations, and premium clinics.
Designated Expert Clinic Appointments
Phone: +86 21 6417 5590 ext. 86500 (English support may be limited).
Hours:
- Monday-Thursday: 10:00-15:00
- Friday: 10:00-12:00
Services: Named expert consultations (appointment-based specialist access).
5. Address Info
Two main campuses:
- Xuhui Campus at 270 Dong'an Road, Xuhui District.
- Pudong Campus at 4333 Kangxin Road, Pudong.